CCR4-deficient macrophages transiently revert to an M2 phenotype, providing a protective effect during the inflammatory response and suggesting that targeting CCR4 may be an effective approach to provide protection against IPF [73]. Here, CCR4 is linked to idiopathic pulmonary fibrosis.